From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Chimeric antigen receptor T-cell therapy represents an innovative approach to immunotherapy and currently stands out, particularly for oncohematological patients refractory to traditional treatments. Ongoing trials are further expanding its clinical use for new oncological and non-oncological indica...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-01-01
|
| Col·lecció: | Hematology, Transfusion and Cell Therapy |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2531137924003195 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
